Levetiracetam Liver Injury: A Benign Antiepileptic Agent?

Yassmin Hegazy; Page Axley; Goo Lee; Meagan Gray

doi:10.14309/crj.0000000000001003

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?

ACG Case Rep J. 2023 Mar 16;10(3):e01003. doi: 10.14309/crj.0000000000001003. eCollection 2023 Mar.

Authors

Yassmin Hegazy^{1

2}, Page Axley^{1

3}, Goo Lee^{1

4}, Meagan Gray^{1

3}

Affiliations

¹ Department of Medicine, University of Alabama Birmingham Hospital, Birmingham, AL.
² Department of Internal Medicine, University of Alabama Birmingham Hospital, Birmingham, AL.
³ Department of Gastroenterology and Hepatology, University of Alabama Birmingham Hospital, Birmingham, AL.
⁴ Department of Pathology, University of Alabama Birmingham Hospital, Birmingham, AL.

Abstract

Levetiracetam is a commonly prescribed antiepileptic agent and has rarely been linked to hepatotoxicity. This case describes a patient with drug-induced autoimmune hepatitis secondary to levetiracetam.

Keywords: autoimmune hepatitis; levetiracetam; liver injury.

Publication types

Case Reports